Work

An open-label, phase Ib study of NEO-PV-01 + adjuvant with nivolumab in patients with melanoma, non-small cell lung carcinoma, or transitional cell carcinoma of the bladder.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.tps3116

Authors: Aung Naing, Siwen Hu-Lieskovan, Ramaswamy Govindan, Kim Allyson Margolin, Melissa Ann Moles, Richard Gaynor, Matthew Jordan Goldstein, Patrick Alexander Ott

Institutions: The University of Texas MD Anderson Cancer Center, University of California, Los Angeles, UCLA Jonsson Comprehensive Cancer Center, Washington University in St. Louis, University of Washington, Dana-Farber Cancer Institute

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2779427112

Cites:

Cited by: 2

Related to: 10